Loading...
The hospitalization burden of inflammatory bowel disease in China: a nationwide study from 2013 to 2018.
He, Yi-Ming Mao, Ren Yuan, Gang Liang, Rui-Ming Long, Jian-Yan Ye, Xiao-Qi Iacucci, Marietta Ben-Horin, Shomron Kaplan, Gilaad G He, Yao
He, Yi-Ming
Mao, Ren
Yuan, Gang
Liang, Rui-Ming
Long, Jian-Yan
Ye, Xiao-Qi
Iacucci, Marietta
Ben-Horin, Shomron
Kaplan, Gilaad G
He, Yao
Citations
Altmetric:
Advisors
Editors
Other Contributors
Departments
Date
13/06/2022
Date Submitted
Keywords
Crohn’s disease
disease burden
hospitalization rate
ulcerative colitis
disease burden
hospitalization rate
ulcerative colitis
Other Subjects
Subject Mesh
Planned Date
Start Date
Collaborators
Principal Investigators
Files
Alternative Titles
Publisher
Abstract
From 2013 to 2018, the hospitalization rates for Crohn's disease (CD) and ulcerative colitis (UC) in China increased from 2.20 (95% CI = 2.17-2.22) to 3.62 (3.59-3.65) per 100,000 inhabitants (p < 0.0001) with an APC of 10.68% (6.00-15.36%) and from 6.24 (6.20-6.28) to 8.29 (8.23-8.33) per 100,000 inhabitants (p < 0.0001) with an APC of 5.73% (2.32-9.15%), respectively. Surgical rates decreased from 7.96% (7.29-8.63%) to 5.56% (5.11-6.00%) for CD patients (p < 0.0001) with APC of -6.30% (-11.33 to -1.27%) and from 3.54% (3.26-3.82%) to 2.52% (2.32-2.72%) for UC patients (p < 0.0001) with APC of -6.35% (-16.21 to 3.51). In 2018, there were estimated 166,000 IBD patients hospitalized costing a total of $426.37 million ($149.91 + $276.46 million) across the entire China.
Language
en
Citation
ISSN
1756-283X
eISSN
ISBN
DOI
10.1177/17562848221102307
PMID
35721841
PMCID
PMC9201315